Breaking News Instant updates and real-time market news.

OCLR

Oclaro

$8.50

0.02 (0.24%)

, FNSR

Finisar

$21.78

0.41 (1.92%)

14:31
09/13/17
09/13
14:31
09/13/17
14:31

Oclaro seen as seller, not buyer, if sector consolidates, Dealreporter says

Oclaro's (OCLR) CEO Gregory Dougherty, who has previously talked about the need for consolidation in the optical components industry, told Dealreporter that his company could either be a buyer or a seller, but three analysts referenced by the publication agree that they see Oclaro as a more likely seller than a buyer, a new report from the deal-focused service stated, according to contacts. The company "has long been rumored" to be a target for rival Finisar (FNSR), though Lumentum (LITE) was mentioned by the analysts as another possible buyer, the report added, according to contacts.

OCLR

Oclaro

$8.50

0.02 (0.24%)

FNSR

Finisar

$21.78

0.41 (1.92%)

LITE

Lumentum

$57.25

-1.25 (-2.14%)

  • 13

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

OCLR Oclaro
$8.50

0.02 (0.24%)

09/05/17
STFL
09/05/17
NO CHANGE
Target $30
STFL
Buy
Finisar estimates lowered following peer commentary at Stifel
Stifel analyst Patrick Newton has lowered his FY18 and FY19 estimates for Finisar (FNSR) and is now modeling one more step down in China following recent commentary from competitors such as Lumentum (LITE), Oclaro (OCLR) and MACOM (MTSI) indicating that China is expected to decline again sequentially in the September quarter. Based on the reduced expectations, he lowered his price target on Finisar shares to $30 from $33, but he maintains a Buy rating on the stock.
08/24/17
STFL
08/24/17
NO CHANGE
STFL
China Mobile tender positive for optical industry, says Stifel
After China Mobile (CHL) released a tender for about 42,200 WDM/OTN device boards and ports, Stifel analyst Patrick Newton says the news are a positive for the optical industry, particularly for investor sentiment. The analyst believes the China Mobile tender is indicative of a thawing in metro tenders and deployments in China, which should eventually bode positively for those exposed to China, specifically Oclaro (OCLR), Lumentum (LITE), and Finisar (FNSR). Nonetheless, Newton continues to see a challenging environment in China, but hopes the September quarter will represent a bottom for fundamentals.
08/24/17
NEED
08/24/17
NO CHANGE
NEED
China Mobile tender offer looks 'significant' for optical stocks, says Needham
Needham analyst Alex Henderson said the coherent transport ports tender offer announced by China Mobile (CHL) on its Chinese language website looks "significant in scale and material" for optical stocks. He noted that NeoPhotonics (NPTN) gets roughly 60% of revenue from China and is directly exposed to coherent demand, while Acacia (ACIA) gets 50% of revenue from China and is also directly exposed. He noted that Oclaro (OCLR), Lumentum (LITE), Finisar (FNSR) all have China exposure, but are less tied to coherent, while adding that "this order has no bearing" on Applied Optoelectronics (AAOI).
08/03/17
STFL
08/03/17
NO CHANGE
STFL
Oclaro reported impressive Q4 results, says Stifel
Stifel analyst Patrick Newton says that Oclaro reported impressive Q4 results, with profitability that "stands out." The analyst adds that the company's CFP2-ACO and QSFP28 products have "positive momentum." He keeps a Buy rating on the shares.
FNSR Finisar
$21.78

0.41 (1.92%)

09/08/17
CHLM
09/08/17
NO CHANGE
Target $28
CHLM
Buy
Finisar price target lowered to $28 from $38 at Craig-Hallum
Craig-Hallum analyst Richard Shannon Finisar's Q2 guidance was "quite poor," though he sees temporary factors far offsetting cyclical factors in October and thinks these should reverse in the near-future. The company blamed a manufacturing process tweak for pushing out 3D sensor sales by a quarter, but Shannon does not think this implies lost share with its lead customer, he tells investors. The analyst lowered his price target on Finisar shares to $28 from $38 but keeps his Buy rating on the stock.
09/08/17
PIPR
09/08/17
NO CHANGE
Target $26
PIPR
Overweight
Finisar outlook disappointing, but demand should improve, says Piper Jaffray
Piper Jaffray analyst Troy Jensen Finisar's July quarter as mixed, with revenue and earnings in-line with expectations while the October quarter guidance came in well below consensus. The analyst believes China demand will start to slowly rebound with excess inventory being worked down. He anticipates a stronger recovery in China during 2018 with 100G metro upgrades likely to begin in the next six months. The analyst lowered his price target for Finisar shares to $26 from $30 and keeps an Overweight rating on the name.
09/08/17
NEED
09/08/17
NO CHANGE
NEED
Finisar price target lowered to $34 from $44 at Needham
Needham analyst Alex Henderson lowered his price target on Finisar after the company cut its Q3 guidance. However, he keeps a Strong Buy rating on the stock.
09/08/17
MKMP
09/08/17
NO CHANGE
MKMP
Finisar catlysts just 'delayed,' not 'canceled,' says MKM Partners
After Finisar's Q2 guidance came in well below expectations, MKM Partners analyst Michael Genovese says that "all of the meaningful catalysts for the stock are delayed, but none are canceled." He says that "the most important catalyst," 3D Sensing, "is only delayed by one quarter," while two other positive catalysts - "full Verizon qualification and demand recovery in China" - "are delayed by 1-2 quarters." He trimmed his price target on the name to $31 from $33 but keeps a Buy rating on the stock.
LITE Lumentum
$57.25

-1.25 (-2.14%)

09/13/17
PIPR
09/13/17
NO CHANGE
Target $68
PIPR
Overweight
Piper reiterates Overweight on Lumentum after Apple unveils 3D sensing
Piper Jaffray analyst Troy Jensen reiterates an Overweight rating on Lumentum Holdings (LITE) with a $68 price target after Apple (AAPL) unveiled 3D sensing in its latest iPhone. Lumentum offers the best way to play the 3D sensing market and the company's time-to-market advantage with Apple will result in ongoing design wins with other smart phone manufacturers, Jensen tells investors in a research note. He believes Lumentum has continued to receive volume production orders since reporting $200M in 3D sensing bookings in the June quarter.
09/13/17
STFL
09/13/17
NO CHANGE
STFL
Buy
3D Sensing applications 'front and center' at Apple launch, says Stifel
Stifel analyst Patrick Newton noted that VCSEL enabled applications were "front and center" during Apple's (AAPL) iPhone X launch event. While there was no explicit mention that there are two VCSEL arrays in the front-facing camera, he remains confident this is the case, adding that the later than expected November 3 shipment date should not materially impact Lumentum's ability to meet its target of over $200M in VCSEL orders in 2017. Newton, who continues to model 80% share for Lumentum's in the initial VCSEL ramp, keeps a Buy rating on the stock.
08/31/17
RSBL
08/31/17
NO CHANGE
RSBL
Lumentum checks indicate exclusive supply deal with Apple, says Rosenblatt
Rosenblatt's research indicates Apple (AAPL) has signed an exclusive supply deal with Lumentum (LITE) on VCSEL laser supply for DOE/WLO structure light solutions.. In the firm's view, Lumentum's VCSEL+DOE structure forms a unique pattern, which would be exclusive for Apple's 3D sensing and help Lumentum maintain a large share at Apple in 2018.

TODAY'S FREE FLY STORIES

CELC

Celcuity

20:34
09/19/17
09/19
20:34
09/19/17
20:34
Syndicate
Celcuity 2.4M share IPO priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

BSTI

BEST Inc

20:33
09/19/17
09/19
20:33
09/19/17
20:33
Syndicate
Best Inc 45M share IPO priced at $10.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

20:25
09/19/17
09/19
20:25
09/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PCRX

Pacira

$35.70

-0.6 (-1.65%)

20:00
09/19/17
09/19
20:00
09/19/17
20:00
Recommendations
Pacira analyst commentary at BMO Capital »

Pacira's Exparel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AVEVF

Aveva

19:56
09/19/17
09/19
19:56
09/19/17
19:56
Upgrade
Aveva rating change at Goldman Sachs »

Aveva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

18:58
09/19/17
09/19
18:58
09/19/17
18:58
Syndicate
Zai Lab announces upsizing of U.S. IPO of American depositary shares »

Zai Lab announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated at Cantor »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated at KeyBanc »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.